Federal contractor profile
INHALON BIOPHARMA, INC.
UEI HFQSJ2GMNRU6CAGE 87U21
Active
Small Business
Overview
- Legal name
- INHALON BIOPHARMA, INC.
- Registered location
- MORRISVILLE, NC, USA
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Sep 22, 2025
Read company summary
INHALON BIOPHARMA, INC. is associated with UEI HFQSJ2GMNRU6 and CAGE 87U21 in public federal records. AcornBids currently links 2 prime awards totaling $5.4M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Defense. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists MORRISVILLE, NC, USA.
At a glance
Lifetime prime obligations$5.4M
Prime awards2
Awards with future end dates2
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 27, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- INHALON BIOPHARMA, INC.
- UEI
- HFQSJ2GMNRU6
- CAGE
- 87U21
- Registered address
- 5151 MCCRIMMON PARKWAY, MORRISVILLE, NC, 27560, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Aug 15, 2025
- Initial registration
- Nov 28, 2018
- Entity start
- Sep 11, 2018
- SAM updated
- Aug 15, 2025
- Registration expires
- Aug 13, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| HT942525CE039A PHASE 1 PLACEBO-CONTROLLED DOSE-ESCALATION SAFETY AND PHARMACOKINETIC STUDY OF IN-007, A NEBULIZED, PAN-SARS ACE2-DECOY THERAPEUTIC FOR PANDEMIC PREPAREDNESS | Department of Defense | $3.2M | Sep 22, 2025 | Dec 31, 2027 |
| HT942524C0076DEVELOPING IN-007 AS A WIDELY DEPLOYABLE INHALED TREATMENT AGAINST PATHOGENS UTILIZING HUMAN ACE2 FOR VIRAL ATTACHMENT AND ENTRY | Department of Defense | $2.2M | Sep 23, 2024 | Dec 22, 2026 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Aug 15, 2025 |
| Source loaded | Sep 2, 2026 |
| Initial registration | Nov 28, 2018 |
| Entity start | Sep 11, 2018 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 541380 — Testing Laboratories and Services | Not reported |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| JOHN WHELAN | Government business | Contact method not published | SAM registration | Not available |
| YING-YING WANG | Alternate government business | Contact method not published | SAM registration | Not available |
| JOHN WHELAN | Electronic business | Contact method not published | SAM registration | Not available |
| YING-YING WANG | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541380 — Testing Laboratories and Services
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
376 awards
207 awards
147 awards
131 awards
119 awards
104 awards
About INHALON BIOPHARMA, INC.
What products and services appear in its federal awards?
Recorded award industries: 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Recorded products and services: AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT; AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH.
Examples from recent award records:
- A PHASE 1 PLACEBO-CONTROLLED DOSE-ESCALATION SAFETY AND PHARMACOKINETIC STUDY OF IN-007, A NEBULIZED, PAN-SARS ACE2-DECOY THERAPEUTIC FOR PANDEMIC PREPAREDNESS
- DEVELOPING IN-007 AS A WIDELY DEPLOYABLE INHALED TREATMENT AGAINST PATHOGENS UTILIZING HUMAN ACE2 FOR VIRAL ATTACHMENT AND ENTRY
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
5151 MCCRIMMON PARKWAY, MORRISVILLE, North Carolina 27560, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Defense.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit